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Abstract
Background: The number of members in the genus Gammapapillomavirus of Family Papillomaviridae has recently
been expanding most rapidly. The aim of this study was to characterize a novel human gammapapillomavirus type
identified in a vaginal swab from a 25-year-old pregnant woman suffering from vaginitis.
Methods: Viral metagenomics method was used to detect the viral sequences in 88 vaginal swab samples
collected from 88 pregnant women with vaginitis. A novel papillomavirus, named HPV-ZJ01 (GenBank no.
KX082661), was detected in one sample and its complete genome sequence was amplified by PCR and sequenced
by Sanger walking. Phylogenetic analyses based on the complete genome and the L1 protein of HPV-ZJ01 and
other representative human papillomaviruses were done, respectively. Further PCR screening was performed in
vaginal swabs (n = 135), cervical smears (n = 40) and cervical cancer tissues (n = 40) using nested-PCR primers
designed based on HPV-ZJ01 sequence to investigate the prevalence of HPV-ZJ01.
Results: The genome of HPV-ZJ01 is 7,358 bp in length with a GC content of 37.8 %. HPV-ZJ01 was predicted to
contain six open reading frames (E6, E7, E1, E2, L2, and L1) and a non-coding long control region (LCR). The
genome shared the highest overall similarity to HPV-166, with 70.6 % nucleotide sequence identity while its L1
gene shared the highest nucleotide similarity to HPV-162, with 71.1 % sequence identity. Phylogenetic analysis
suggested that HPV-ZJ01 belongs to a novel HPV type in the Gamma-PV genus, species Gamma-19, already
containing HPV161, HPV162 and HPV166. PCR screening results indicated that none of the other samples were
positive for HPV-ZJ01 except the original HPV-ZJ01 positive vaginal swab specimen.
Conclusion: The genome sequence of a novel type of species Gamma-19 HPV was characterized. The screening
PCR results suggested that HPV-ZJ01 is not associated with any of the cervical cancer samples tested. In order to
confirm the prevalence and disease association, if any, for HPV-ZJ01, a further study with different sample types and
a larger sample size is needed.
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Background
Human papillomaviruses (HPVs) belong to family Papil-
lomaviridae, with small, circular, double-stranded DNA
genomes [1]. Papillomaviruses are highly diverse and in-
fect human epithelial cells, where some species are im-
plicated in the development of several benign and
malignant neoplasms [1, 2]. Based on the nucleotide
similarity in the L1 open reading frame (ORF), HPVs are
classified into genera, species and types [1, 3]. HPV types
that display less than 60 % nucleotide sequence similar-
ity in the L1 open reading frame (ORF) are classified
into different genera, while viral species share 60–70 %
nucleotide sequence similarity, and types show at least
90 % [1]. The taxonomy of papillomaviruses at the spe-
cies level and above is overseen by the International
Committee for the Taxonomy of Viruses; while, HPV type
designation and classification below the species level is
maintained by the International HPV Reference Center at
the Karolinska Institute, Stockholm, Sweden [4]. As of
May 6, 2016, two hundred and one different HPV types,
ranging from HPV-1 to HPV-205, were officially recog-
nized, including 65 Alphapapillomaviruses (Alpha-PVs),
51 Betapapillomaviruses (Beta-PVs), 81 Gammapapilloma-
viruses (Gamma-PVs), 3 Mupapillomaviruses (Mu-PVs),
and a single Nupapillomavirus (Nu-PV) [5]. Four previ-
ously recognized HPV types (HPV-46, HPV-55, HPV-64
and HPV-79) were recently re-classified as subtypes
(HPV-79 was replaced by HPV91) [6–8].
As more HPV types are discovered, it is necessary to
confirm the genomic characteristics and the clinical rele-
vance of these new HPV types. Although a variety of la-
boratory techniques for detecting known HPVs are
available, an efficient laboratory method for the identifi-
cation of divergent HPVs from different biological sam-
ples is required.
Viral metagenomics is a useful method that can non-
specifically detect both already known and highly diver-
gent viruses. Non capsid protected host-derived back-
ground DNA and RNA in biological samples can be
digested by nuclease treatment and nucleotide sequence
information from viral particles associated nucleic acids
determined by sequence-independent amplification and
deep sequencing to allows the identification of viruses
recognizable through their nucleotide or translated pro-
tein sequence homologies to all known viruses. With the
advent of viral metagenomics [9–12] and the use of rolling
circle amplification (RCA) which preferentially amplifies
DNA circles [13, 14], it becomes possible to obtain the
complete genome of new HPVs at relatively high speed.
In the present study, a viral metagenomic method was
applied to vaginal swab samples collected from pregnant
women, and identified a novel gamma papillomavirus in
a sample from a 25-year-old pregnant woman suffering
from vaginitis. We describe here the genome and
phylogenetic analysis of this novel Gamma-PV type.
Type-specific PCR primers were also developed to test a
representative collection of various clinical specimens.
Methods
Sample collection and metagenomic analysis
From Jan. 2014 to Jan. 2015, 88 vaginal swab specimens
were collected from 88 pregnant women with vaginitis
in the affiliated Maternity and Infant Hospital of Jiangsu
University, China. Swab specimens were re-suspended in
500ul of phosphate-buffered saline (PBS) and vigorously
vortexed for five min. The suspension of each sample
was subjected to centrifugation (10 min, 15,000 × g). The
supernatant was filtered through a 0.45-μm filter
(Millipore) to remove eukaryotic and bacterial cell-
sized particles. The filtrates enriched in viral particles
were treated with DNase and RNase to digest unpro-
tected nucleic acid at 37 °C for 60 min [15]. Remaining
total nucleic acid was then isolated using QiaAmp
Mini Viral RNA kit (Qiagen) according to manufac-
turer’s protocol. Six separate pools were randomly gen-
erated, 5 of which contained nucleic acid from 15
specimens while one included 13 specimens. Six librar-
ies were then constructed using Nextera XT DNA
Sample Preparation Kit (Illumina) and sequenced using
the MiSeq Illumina platform with 250 bases paired ends
with dual barcoding for each pool. Bioinformatics analysis
was performed according to a previous study [16].
Finding and genome sequencing of the novel HPV
Viral metagenomics analysis indicated that one pool
contained 30 sequence reads generating 11 different
contigs ranging from 152 bp to 612 bp in length with
amino acid homology to but significantly divergent from
known HPV genomes in GenBank. PCR screening of the
15 individual samples in this pool with a set of nested
primers designed on the 612 bp contig indicated that a
single sample was positive. PCR to bridge sequence gaps
were then used to acquire the whole genome of the
novel HPV. PCR fragments were cloned in T-vectors
and sequenced by Sanger walking. Sequences and char-
acteristics of the primers used in PCR screening and
genome determination are shown in Table 1.
PCR screening
In order to assess the prevalence of HPV-ZJ01 and
whether this novel HPV strain was associated with cer-
vical carcinoma, PCR was performed to screen the ori-
ginal 88 vaginal swab specimens, plus 128 samples from
128 patients suffering from cervical carcinoma, including
40 cancer tissues, 40 cervical smears, and 48 vaginal
swab specimens, collected in 2014–2016 from the affili-
ated Maternity and Infant Hospital of Jiangsu University,
China. All samples were frozen immediately at −80 °C
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until further processing. Before nucleic acid extraction,
tissue samples were homogenized, frozen and thawed on
dry ice three times. Nucleic acids were extracted by
QiaAmp Mini Viral RNA kit (Qiagen). Two sets of PCR
screening primers were designed based on the genome
sequence of HPV-ZJ01 (Table 1). Standard precautions
were used for all procedures to reduce the possibility of
sample contamination by amplified DNA molecules.
Negative and positive controls were included from nu-
cleic acid extraction to PCR screening. The original
HPV positive swab sample identified in this study was
used as positive control. PBS was used as negative con-
trol instead of samples during nucleic acid extraction,
while deionized water was used as negative control in-
stead of nucleic acid template in PCR screening.
Phylogenetic analysis
Phylogenetic analyses were performed including the
closest viral relatives based on best BLASTx hits and
representative members of related viral species and gen-
era. Sequence alignment was performed using CLUS-
TALW with the default settings. A phylogenetic tree with
1000 bootstrap resamples of the alignment data sets was
generated using the maximum likelihood method based
on Jones-Taylor-Thornton (JTT) model in MEGA6.0.
Bootstrap values (based on 1000 replicates) for each node
are given. Putative ORFs in the genome were predicted by
NCBI ORF finder. Informed consents were provided by all
participants included in the present study. Ethical
Approval was given by Ethics Committee of Jiangsu
University and the reference number is No. JSU2015045.
Nucleotide sequence accession numbers
The genome sequence of HPV-ZJ01 was deposited in
GenBank under the accession number: KX082661.
Results
Genomic organization
The complete circular genome of HPV-ZJ01 is 7,358 bp in
length with a GC content of 37.8 %. The HPV-ZJ01 gen-
ome was predicted to contain six ORFs coding for four
early proteins (E6, E7, E1, and E2) and two late proteins
(L1 and L2) (Fig. 1). In addition, there was a 655 bp non-
coding long control region (LCR), at position 6,704
through 7,358 of the genome, also known as an upstream
regulatory region (URR) located between the L1 and E6
genes. The ‘A’ in the first ATG codon of the ORF E6 was
assigned position 1 in the sequence. This LCR contains a
putative TATA box (TATAAA, nucleotide positions 7,317-
7,322), a putative polyadenylated site (AATAAA, nucleo-
tide positions 6,929-6,934), three putative E1 binding sites
(consensus sequence: AACAAT, nucleotide positions
6,799-6,804; 6,834-6,839 and 7,256-7,261), probably repre-
senting the origin of replication [13, 17], two palindrome
sites (ACCG-N4-CGGT; nucleotide positions 7,080–
7,091; 7,122–7,133) and three degenerate palindromes
(ACC-N6/7-GGT, positions 6,795-6,807; 7,232-7,243 and
7,302-7,313). The palindrome motif ACCG-N4-CGGT is
known to play a crucial role in binding of the E2 protein
Table 1 nested primers used to detect the positive sample of HPV-ZJ01 and amplify the gaps between contigs
Primers’ name Sequence (5′to 3′) Primers′ name Sequence (5′to 3′)
Detection FO AAATGAAACGCGGCAAGATCC Primer4 FI TGGCAAAAAGTGCAAGGAACTG
Detection RO TCGGTTGCTCTTGGACTACG Primer4 RI AAGGCATACAGCATTCTACTCC
Detection FI CGCGGCAAGATCCTGCAAATCA Primer5 FO AAGGGGACACATGGGCAGAT
Detection RI GCTGTGTGCCTTCGTACCGGG Primer5 RO GCGGGAAACTGAGCCTAAGAA
Primer1 FO GCTTGATGACTTTTGTTCTCACT Primer5 FI AGGTACTGGTAGGGGGTCTG
Primer1 RO TAAGTGGACCTCCCATGCTG Primer5 RI CTTGGACAGGCGTGCTAGAT
Primer1 FI AGGATCTTGCCGCGTTTCATT Primer6 FO TCTTAGGCTCAGTTTCCCGC
Primer1 RI TAAGTGGACCTCCCATGCTG Primer6 RO AGTCTGTGGGCTTAATAGGCG
Primer2 FO GTCAGCATGGGAGGTCCACT Primer6 FI CCGCCTTTGAACCAGATGTC
Primer2 RO TGCTGCATTAGTATCAGTTTCTGC Primer6 RI CCAACCTGCAAGCCACTTCT
Primer2 FI ATGAGAATGTGGATGCTGAGGA Primer7 FO TCTGCAATGACCACCAGAAGT
Primer2 RI AGCCCACTGTATCATTCGAGAC Primer7 RO AGAGAACCACTAGGTGAAGCAA
Primer3 FO GTGACAGATGTAAAACCGAAGG Primer7 FI GGCCTGTCCATTTTTATCAGGA
Primer3 RO TGCCCATTTGAATAGCTTGCTT Primer7 RI CACTGGAAGGTGTTGAATTTCC
Primer3 FI GTGACAGATGTAAAACCGAAGG Primer8 FO GAGAGCTCAAGGACCAAACAA
Primer3 RI AGCTTGCTTAGCATTATTTTCAGAT Primer8 RO AAGGATGTCCAGATGTGACTG
Primer4 FO GCCTTGCCTTATCCTTGTTGG Primer8 FI GAGAGCTCAAGGACCAAACAA
Prime4 RO AGCACGTTTATTTCTACCAGCTC Primer8 RI TAACAAGCACCAAACAACTCCC
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[18, 19], which mediates viral transcription in trans
[20]. The putative E6 protein contains two conserved
zinc-finger domains (CxxC(x)29CxxC) at positions
79–189, 298–408 and are separated by 36 amino
acids. The putative E7 protein, located downstream
of E6 ORF, contains only one zinc-finger domain at
position 579–689 as well as the tumor suppressor
(pRB) binding domain (LXCXE) at position 489–503
[21, 22]. One conserved ATP-binding site of the
ATP-dependent DNA helicase (GPPDSGKS [G-X4-
GKT/S]) was identified at position 1,993-2,016 in the
putative E1 protein, encoded by the largest ORF (603
amino acid residues) [23]. No conserved leucine-
zipper domain (L-X6-L-X6-L-X6-L), necessary for E2
dimerization, was observed in the carboxyterminal
part of the putative E2 protein of HPV-ZJ01.
We identified the characteristic donor (AAG/GUASNR)
and acceptor (GUYACYAG/YU) RNA splicing sites
[13, 24–26] and it is likely that the E4 protein is translated
from a spliced mRNA, containing the first few codons of
the E1 ORF joined to the E4 sequence (Fig. 1, E1^E4, cod-
ing sequence consisting of genomic positions nt 709–727
and 3,061-3,398), as described previously for other HPV
types [13, 24–26]. The resulting putative E1^E4 fusion
protein contains a typically high content of proline, with
13 proline residues out of 118 amino acids (11 %).
Sequence and phylogenetic analysis
Sequence analysis indicated that the L1 gene of the
HPV-ZJ01 shares the highest nucleotide (nt) sequence
identity (71.1 %) with HPV162, which was isolated from
human healthy skin in China belonging to a member
of the genus Gammapapillomavirus [27]. According to
the International Committee on Taxonomy of Viruses
(ICTV), the members of a papillomavirus species
should share at least 70 % nt sequence identity over
the L1 gene [3], it is therefore inferred that HPV-ZJ01
belongs into the Gamma-PV genus, species Gamma-
19, already containing HPV161, HPV162 and HPV166.
The nt sequence identities of L1 gene between HPV-
ZJ01 and HPV161 and HPV166 were 69.1 % and
70.3 %, respectively. At the complete genome level,
HPV-ZJ01 shares 69.5 %, 69.6 % and 70.6 % nt se-
quence identities with HPV161, HPV162 and HPV166,
respectively. Table 2 shows the identities of the puta-
tive proteins of HPV-ZJ01 to the analogous proteins of
HPV161, HPV162 and HPV166. Interestingly, the E6
and L2 proteins of HPV-ZJ01 are most closely related
to those of HPV166, whereas the E1 and E2 proteins are
closest to HPV161. E7 shares the same 64 % identity with
HPV162 and HPV166 while L1 is closest to that of type
162, sharing 68.7 % amino acid sequence identity.
To characterize the phylogenetic relationship between
HPV-ZJ01 and related HPVs, the entire L1 protein se-
quence of HPV-ZJ01 and the representative HPV types
from other species and genera were aligned to generate
a phylogenetic tree, as the L1 gene is well conserved and
often used for classification. A phylogenetic tree based
on the complete genome of HPV-ZJ01 and the related
HPV strains was also constructed to confirm the phylo-
genetic analysis results based on the L1 protein. Both
trees clustered the representative HPVs well in their re-
spective genera, including Gamma-, Alpha-, Beta-, Mu-
and Nupapillomavirus, where HPV-ZJ01 clustered within
the genus Gammapapillomavirus, species 19 with a boot-
strap value of 100 %, forming a monophyletic group with
HPV161, HPV162 and HPV166 (Fig. 2a and b).
PCR screening result
PCR screening results indicated that except the ori-
ginal HPV-ZJ01 positive vaginal swab specimen, none
of the other vaginal swabs (n = 135), cervical smears
(n = 40) and cervical cancer tissues (n = 40) samples
were positive.
Fig. 1 Genomic organization of HPV-ZJ01. Genomic positions of viral
genes (E6, E7, E1, E2, E1^E4, L1 and L2) and the non-coding region
(LCR) located between L1 and E6 are indicated
Table 2 Identity of HPV-ZJ01 Amino Acid Sequences with
Related HPVs
HPV-ZJ01 E6 E7 E1 E2 L2 L1
HPV161 56.8 % 60.0 70.8 63.7 62.3 67.4
HPV162 58.3 64.0 69.8 62.6 62.6 68.7
HPV166 59.7 64.0 70.7 61.1 62.9 68.3
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Discussion
The advent of metagenomics using high-throughput se-
quencing technology [9–12] facilitates the discovery of
novel viruses at a relatively low cost and unprecedented
speed, assists in the study of viral diversity, and the asso-
ciation of virus and disease [28–30]. We report here the
genome of HPV-ZJ01, a novel human gammapapilloma-
virus type identified from a vaginal swab sample of a
pregnant woman, whose L1 gene shares 71.1 % nucleo-
tide identity with that of HPV162, its closest relative.
Phylogenetic analysis confirmed that HPV-ZJ01 clusters
with other Gammapapillomaviruses in species 19
(HPV161, HPV162 and HPV166), all of them containing
the typical HPV ORFs, coding for four putative early
proteins (E6, E7, E1, E2), and two late capsid proteins
(L2 and L1). Due to the presence of the characteristic
donor (AAG/GUASNR) and acceptor (GUYACYAG/
YU) RNA splicing sites in E1 and E2 ORFs, respectively
[13, 24–26], from HPV-ZJ01, HPV161, HPV162 and
HPV166, it is most likely that the E4 proteins of these
four HPVs are translated from a spliced mRNA, contain-
ing the first few codons of the E1 ORFs joined to the E4
sequence. The resulting putative E1^E4 fusion proteins
contain a typically high content of proline, which repre-
sents 11 %, 13.27 %, 10 % and 10 % of E1^E4 amino
acid sequences of HPV-ZJ01, HPV161, HPV162, and
HPV166, respectively.
Analysis of genome organization of HPV-ZJ01,
HPV161, HPV162 and HPV166 revealed that they share
many similarities and some differences. Two conserved
zinc-binding domains of CxxC(x)29CxxC separated by
36 amino acids are found at the same position away
from the N-terminal end of E6 protein of these four
HPVs, respectively. Additionally, the E7 proteins of
them also contain a single zinc-binding domain of
CxxC(x)29CxxC at the same position, respectively. The
putative LXCXE motif found in the E7 protein of HPV-
ZJ01, also identified in the three HPVs of Gamma
genus, species 19 is a canonical pRB-binding motif and
has been implicated in the transformation of host cells
[21, 31, 32]. A homologous LXCXE motif is used to
bind to the pocket region of pRB, P107 and P130 and
prevent inter-actions with the transcription factor E2F-
1 by most HPV E7 proteins [33]. The E1 of HPV-ZJ01
contains the conserved ATP-binding site of the ATP-
dependent helicase (GPPDSGKS), nevertheless, in com-
parison, the motif is GPPDTGKS in all of the other
three HPVs, with the Serine being replaced by Threo-
nine. The putative E2 protein of HPV-ZJ01 contains no
conserved leucine-zipper domain (L-X6-L-X6-L-X6-L),
necessary for E2 dimerization. This domain is also
missing in HPV161, 162 and 166. In the LCR of both
HPV-ZJ01 and HPV161, a putative TATA box (TATAAA)
of the E6 promoter is identified 36 and 34 nt upstream of
the first start codon of the E6 ORF, respectively, while the
classical TATA box (TATAAA) was not detected in the
LCR of HPV162 and HPV166. Similarly, three and two E1
binding sites (AACAAT) are found in the LCR of HPV-
ZJ01 and HPV161, respectively, while none is detected in
the LCR of HPV162 and 166. As for the polyadenylation
sites, the LCR of HPV-ZJ01 and HPV162 each contain
one and HPV161 and HPV166 each contain two. Notably,
Fig. 2 Phylogenetic trees based on the L1 gene (a) and complete genome (b) of HPV-ZJ01 and other representative human papillomaviruses.
The HPV-ZJ01 sequence determined in this study is labeled by black rhombus
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for HPV161, its LCR simply contains two copies of the
12-basepair palindrome motif ACCG-N4-CGGT, known
to play a crucial role in binding of the E2 protein [18, 19].
However, in the other three HPVs (HPV-ZJ01, HPV162,
HPV166), both palindrome sites (ACCG-N4-CGGT) and
degenerate palindrome sites (ACC-N6/7-GGT) are simul-
taneously present in their LCRs. HPV-ZJ01 contains two
palindrome sites (ACCG-N4-CGGT) and three degener-
ate palindrome sites (ACC-N6/7-GGT) in its LCR, while
the LCR of HPV162 only contains one palindrome site
(ACCG-N4-CGGT), and the other three E2 binding sites
are represented by the degenerate ones (ACC-N6-GGT).
Only one palindrome site (ACCG-N4-CGGT) and four
degenerate palindrome sites (ACC-N6-GGT) are in the
LCR of HPV166.
HPV types have traditionally been classified as muco-
sal or cutaneous on the assumption that HPV tissue
tropism is reflected in the location where the genome of
the particular type was found [13, 34]. Accordingly, HPV
types belonging to the Alpha-PVs are predominantly
assigned as anogenital types and Beta-PVs, Gamma-PVs,
Mu-PVs and Nu-PVs as cutaneous types [2, 34]. How-
ever, a growing body of evidence suggests that HPV
types belonging to Gamma-PVs (the genus whose known
members has recently been expanding most rapidly) are
ubiquitous and show broader tissue tropism than previ-
ously thought [13], with reported detection sites ranging
from healthy skin and various cutaneous lesions [35–38]
to genital lesions [39] and oral [34] and nasal [40] mu-
cosa. One recent report suggests that Gamma-PVs are
also able to infect mucocutaneous sites such as the anal
canal [41] and even the possibility of dual tropism of
Gamma HPVs was recently proposed [26]. Here, HPV-
ZJ01, confirmed to be a member of Gamma-PV genus,
species 19 and identified in a vaginal swab can be pre-
liminarily classified as mucosal. However, as its closest
relatives (HPV161, HPV162 and HPV166) were iso-
lated from healthy skin [27], the tropism of HPV-ZJ01
remains to be definitely established as different PV
types classified in a specific species typically share bio-
logical and pathological properties [3]. The 25-year-old
pregnant woman in whom we identified HPV-ZJ01 was
suffering from vaginitis. Whether the presence of
HPV-ZJ01 was at all related to this condition or indir-
ectly facilitated viral replication is not known. No skin
or mucosal lesion was noted by the attending
gynecologist. In humans, cutaneous HPVs are highly
prevalent in the general population, where they usually
are contained by the immune system and result in sub-
clinical infections. These infections however tend to
become clinically apparent upon genetic, acquired, or
iatrogenic deficiencies in cell-mediated immunity, and
cutaneous HPVs have been linked to non-melanoma
skin cancer in these patients [42].
Here we screened total 216 samples including vaginal
swabs, cervical carcinoma tissues and cervical smears
from cervical carcinoma patients using PCR methods.
The negative PCR results suggested that HPV-ZJ01 may
not be associated with cervical cancer. Further studies
with different sample types and a larger sample size are
needed to clarify the prevalence and disease association,
if any, for HPV-ZJ01.
Conclusion
A novel HPV type named HPV-ZJ01 was identified in a
vaginal swab sample from a 25 years old pregnant
woman with vaginitis and its genome was characterized.
Comparative characterization of HPV-ZJ01 and its clos-
est relatives and phylogenetic analysis demonstrated that
it is a novel HPV type and clusters into the Gamma-PV
genus, species Gamma-19. No evidence of disease asso-
ciation of the new HPV type was found.
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